References

Agnew, B. 1996. Body-Count Budgeting: New Pressure to Shift Funding Among Diseases. Journal of NIH Research June 1996:21-22.


Biotechnology Industry Organization. 1998. 1997-98 BIO's Citizens' Guide to Biotechnology [WWW document]. URL http://www.bio.org/whatis/citizenl.dgw (accessed June 18, 1998).


Cohen, J. 1993a.Conflicting Agendas Shape NIH. Science 261:1674-1679.

Cohen, J. 1993b. Is NIH's Crown Jewel Losing Luster? Science 261:1120-1127.


Institute of Medicine. 1976. The Current Burden of Illness in the United States. Washington, D.C.: National Academy Press.

Institute of Medicine. 1984. Responding to Health Needs and Scientific Opportunity: The Organizational Structure of the National Institutes of Health. Washington, D.C.: National Academy Press.

Institute of Medicine. 1988. Report of a Study: A Healthy NIH Intramural Program: Structural Change or Administrative Remedies? Washington, D.C.: National Academy Press.

Institute of Medicine. 1990. Funding Health Services Research: A Strategy to Restore Balance. Washington, D.C.: National Academy Press.

Institute of Medicine. 1991. The AIDS Research Program of the National Institutes of Health. Washington, D.C.: National Academy Press.

Institute of Medicine. 1994. Careers in Clinical Research: Obstacles and Opportunities. Washington, D.C.: National Academy Press.

Institute of Medicine. 1997. Enabling America. Washington, D.C.: National Academy Press.


Johnson, J. A. 1998. Disease Funding and NIH Priority Setting. CRS Report for Congress. Report 97-917 STM. Washington, D.C.: Congressional Research Service.


Klausner, R. D. 1992. Report of the Task Force on the Intramural Research Program of the National Institutes of Health. Bethesda, Md.: National Institute of Child Health and Human Development.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 81
--> References Agnew, B. 1996. Body-Count Budgeting: New Pressure to Shift Funding Among Diseases. Journal of NIH Research June 1996:21-22. Biotechnology Industry Organization. 1998. 1997-98 BIO's Citizens' Guide to Biotechnology [WWW document]. URL http://www.bio.org/whatis/citizenl.dgw (accessed June 18, 1998). Cohen, J. 1993a.Conflicting Agendas Shape NIH. Science 261:1674-1679. Cohen, J. 1993b. Is NIH's Crown Jewel Losing Luster? Science 261:1120-1127. Institute of Medicine. 1976. The Current Burden of Illness in the United States. Washington, D.C.: National Academy Press. Institute of Medicine. 1984. Responding to Health Needs and Scientific Opportunity: The Organizational Structure of the National Institutes of Health. Washington, D.C.: National Academy Press. Institute of Medicine. 1988. Report of a Study: A Healthy NIH Intramural Program: Structural Change or Administrative Remedies? Washington, D.C.: National Academy Press. Institute of Medicine. 1990. Funding Health Services Research: A Strategy to Restore Balance. Washington, D.C.: National Academy Press. Institute of Medicine. 1991. The AIDS Research Program of the National Institutes of Health. Washington, D.C.: National Academy Press. Institute of Medicine. 1994. Careers in Clinical Research: Obstacles and Opportunities. Washington, D.C.: National Academy Press. Institute of Medicine. 1997. Enabling America. Washington, D.C.: National Academy Press. Johnson, J. A. 1998. Disease Funding and NIH Priority Setting. CRS Report for Congress. Report 97-917 STM. Washington, D.C.: Congressional Research Service. Klausner, R. D. 1992. Report of the Task Force on the Intramural Research Program of the National Institutes of Health. Bethesda, Md.: National Institute of Child Health and Human Development.

OCR for page 81
--> McGinnis, J. M., and W. H. Foege. 1993. Actual Causes of Death in the United States. Journal of the American Medical Association 270:2207-2212. National Institutes of Health. 1994a.Report of the External Advisory Committee of the Director's Advisory Committee, The Intramural Research Program, National Institutes of Health . Bethesda, Md.: National Institutes of Health. National Institutes of Health. 1994b. Section 1125, NIH Organization and Functions. In NIH Manual. Bethesda, Md.: National Institutes of Health (revised October 1, 1994). National Institutes of Health. 1996. Report of the NIH AIDS Research Program Evaluation Working Group of the OARAC. Bethesda, Md.: National Institutes of Health. National Institutes of Health. 1997a. Disease-Specific Estimates of Direct and Indirect Costs of Illness and NIH Support, 1997 Update. Bethesda, Md.: National Institutes of Health. National Institutes of Health. 1997b. Setting Research Priorities at the National Institutes of Health. Bethesda, Md.: National Institutes of Health. National Institutes of Health. 1997c. Review Criteria for and Rating of Unsolicited Research Grant and Other Applications. NIH Guide 26:22. National Institutes of Health. 1997d. NIH Organization Handbook. Bethesda, Md.: National Institutes of Health. National Institutes of Health. 1998a. Press Release for the President's FY 1999 Budget for the National Institutes of Health, February 2. Bethesda, Md.: National Institutes of Health. National Institutes of Health. 1998b. General Background Information-National Institutes of Health (NIH) [WWW document]. URL http://www.nih.gov/welcome/nihnew.html (accessed May 13, 1998). National Institutes of Health. 1998c. The President's Fiscal Year 1999 NIH Budget Summary, February 2, 1998 [WWW document]. URL http://www.nih.gov/news/Budget99/BUDGET99.HTM (accessed May 13, 1998). National Institutes of Health. 1998d. Examples of How Research Priorities Have Been Affected by Public Input. Provided to the Committee on the NIH Research Priority Setting Process by the Office of Science Policy, NIH, April 2. Bethesda, Md.: National Institutes of Health. National Research Council. 1989. Improving Risk Communication. Washington, D.C.: National Academy Press. National Research Council. 1996. Understanding Risk. Washington, D.C.: National Academy Press. National Science Foundation. 1997a. Federal R&D Funding by Budget Function, Fiscal Years 1994-1996. NSF 97-301. Arlington, Va.: National Science Foundation. National Science Foundation. 1997b. Federal Funds for Research and Development, Fiscal Years 1995, 1996, and 1997, Vol. 45, Detailed Statistical Tables. NSF 97327. Arlington, Va.: National Science Foundation. Nature. 1993. NIH: A Strategy for the 21st Century? Nature363:99-100. NIH Director's Panel on Clinical Research. 1997. Report to the Advisory Committee to the NIH Director. Bethesda, Md.: NIH Director's Panel on Clinical Research . Office of Management and Budget. 1997. Instructions for the Preparation and Submission of Annual Budget Estimates. Circular A-1 1. Washington, D.C.: Office of Management and Budget.

OCR for page 81
--> Pharmaceutical Research and Manufacturers of America. 1997. 1997 Industry Profile. Washington, D.C.: Pharmaceutical Research and Manufacturers of America. Rettig, R. A. 1977. Cancer Crusade: The Story of the National Cancer Act of 1971. Princeton, N.J.: Princeton University Press. Stephens, M. 1993. Testimony before the President's Cancer Panel, Special Commission on Breast Cancer. Reston, Va. July 21. Strickland, S. P. 1972. Politics, Science, and Dread Disease: A Short History of United States Medical Research Policy. Cambridge, Mass.: Harvard University Press. U.S. Congress. 1993. Conference Committee Report Accompanying NIH Reauthorization Act of 1993. Washington, D.C.: U.S. Government Printing Office. U.S. Congress. 1997a. P.L. 105-78, Sec. 213. U.S. Departments of Labor, Health and Human Services, and Education Appropriations Act of 1998. Washington, D.C.: U.S. Government Printing Office. U.S. Congress. 1997b. Congressional Record, September 3, 1997. Washington, D.C.: U.S. Government Printing Office. U.S. Department of Health, Education, and Welfare. 1976. Report of the President's Biomedical Research Panel. DHEW Publication No. (OS) 76-500. Washington, D.C.: U.S. Department of Health, Education, and Welfare. U.S. Department of Health and Human Services. 1998. Justification of Estimates for Appropriations Committees, FY 1999, NIH, Vol. V, Office of the Director. Washington, D.C.: U.S. Department of Health and Human Services. U.S. House of Representatives. 1997a. Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for 1998, Hearings before the Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies, House Committee on Appropriations. Washington, D.C.: U.S. Government Printing Office. U.S. House of Representatives. 1997b. Overview of NIH Programs, Hearing before Subcommittee on Health and Environment of the House Committee on Commerce. Serial No. 105-43. Washington, D.C.: U.S. Government Printing Office. U.S. Senate. 1996. Report Accompanying S. 1897, NIH Revitalization Act of 1996. Washington, D.C.: U.S. Government Printing Office. U.S. Senate. 1997a. Biomedical Research Priorities: Who Should Decide? Senate Hearing 105-68. Washington, D.C.: U.S. Government Printing Office. U.S. Senate. 1997b. Coordination of NIH Research Efforts: Three Case Studies. Senate Hearing 105-188. Washington, D.C.: U.S. Government Printing Office. U.S. Senate. 1997c. Support Strategies for Clinical Research and Alternative Medicine at the NIH. Senate Hearing 105-246. Washington, D.C.: U.S. Government Printing Office. Varmus, H. 1997. Interview with Harold Varmus. Journal of NIH Research 9(8):21-25. White House. 1965. Biomedical Science and Its Administration: A Study of the National Institutes of Health. Washington, D.C.: White House. Wingo, P. A., L. A. G. Ries, H. M. Rosenberg, D. S. Miller, and B. K. Edwards. 1998. Cancer Incidence and Mortality, 1973-1995. Cancer (Cancer Cytopathology) 82:1197-1207.

OCR for page 81
This page in the original is blank.